Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05138289 · ClinicalTrials.gov registry record
The REVEALPLAQUE Study: A pRospEctiVe, multicEnter Study to AnaLyze PLAQUE Using CCTA
A clinical trial, sponsored by HeartFlow.
- Completed
- Registry status
- 258
- Enrollment target
NCT05138289 is a clinical trial that has completed, run by HeartFlow. The registered enrollment target is 258 participants.
The verdict
NCT05138289 has completed, sponsored by HeartFlow.
- COMPLETED
- Registry status
- 258 participants
- Enrollment target
Study Summary
This study will evaluate the level of agreement between noninvasive CCTA (coronary computed tomography angiography)-based quantification and characterization of coronary atherosclerosis and invasive IVUS (intravascular ultrasound).
Interventions
- OTHER Total Plaque Volume
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 258 participants |
| Start Date | 2021-10-12 |
| Est. Completion | 2022-11-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05138289
The ClinicalTrials.gov registry entry for NCT05138289 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 258 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is HeartFlow, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Total Plaque Volume is the first listed.
NCT05138289 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05138289 about?
NCT05138289 is a clinical study titled "The REVEALPLAQUE Study: A pRospEctiVe, multicEnter Study to AnaLyze PLAQUE Using CCTA". This study will evaluate the level of agreement between noninvasive CCTA (coronary computed tomography angiography)-based quantification and characterization of coronary atherosclerosis and invasive IVUS (intravascular ultrasound).
What is the current status of trial NCT05138289?
This trial is currently completed. The enrollment target is 258 participants. The study started on 2021-10-12. Estimated completion is 2022-11-08.
What interventions are being tested in trial NCT05138289?
The interventions under investigation include: Total Plaque Volume (OTHER).
Who is sponsoring clinical trial NCT05138289?
This trial is sponsored by HeartFlow, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.